Pharmaceutical formulations and methods and uses comprising an incretin receptor agonist and an amylin receptor agonist
PK202600621A0Pending Publication Date: 2026-07-27ELI LILLY & CO
0 Cites 0 Cited by
Patent Information
- Application Number
- PK202600621
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-07-09
- Publication Date
- 2026-07-27
Need to check novelty before this filing date? Find Prior Art
No text content released.